Table 1.
Biochemical and clinical patient data before and after 12 months of MAD treatment.
| T0 | 12 months | |
|---|---|---|
| Weight (kg) | 67 | 64 |
| Plasma glucose g/dl | 82 | 59 |
| C-LDL g/dl | 129 | 154 |
| C-HDL g/dl | 30 | 35 |
| TG g/dl | 111 | 134 |
| Plasma uric acid g/dl | 5.5 | 9.7 |
| CK U/l | 508 | 327 |
| CK mass U/l | 10.4 | 7.2 |
| CK activity U/l | 27 | 19 |
| NT-proBNP pg/ml | 3010 | 2570 |
| AST U/l | 122 | 87 |
| ALT U/l | 111 | 85 |
| GGT U/l | 133 | 38 |
| LDH U/l | 745 | 518 |
| ALP U/l | 234 | 129 |
| PTH pg/ml | 107 | 111 |
| Plasma creatinine g/dl | 1.2 | 0.7 |
| Plasma urea g/dl | 47 | 22 |
| GFR ml/min/m2 | 78 | 123 |
| EF % | 30 | 45 |
| Steps /24h | 1300 | 2800 |
| Hr-QoL Physical component | 42/100 | 58/100 |
| Hr-QoL Mental component | 48/100 | 52/100 |